BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

South Korea

MFDS Greenlights VUNO Med®-DeepCARS™, AI Medical Device for Cardiac Arrest Prediction

VUNO Med®–DeepCARS™ is a breakthrough AI-driven medical device that analyzes the potential risk of cardiac arrest using four primar...

August 24, 2021 | News

HDT Bio ,Korea’s Quratis to Co-Develop COVID-19 Vaccine in Asia

HDT Bio Corp., a developer of immunotherapies for oncology and infectious diseases, announced today an agreement with Korean biotech Quratis Inc. to co-dev...

August 18, 2021 | News

Fujifilm Introduces its AI-powered Product for Chest X-ray in Japan, in Collaboration with Lunit

Fujifilm Corporation, a global medical imaging device provider, today announced its AI-powered product for analyzing chest X-ray 'CXR-AID' will be commerci...

August 13, 2021 | News

South Korea to Expand patient access to incision-free Focused Ultrasound treatment

Insightec®, a global healthcare company focused on creating the next generation of patient care, announced Seoul National University Ho...

August 09, 2021 | News

Yuyu Pharma Signs Exclusive Distribution Agreement with Novartis Korea

Yuyu Pharma, a pharmaceutical company based in Korea, and Novartis Korea announced today that the companies have entered into an agreement in which Yuyu wi...

August 04, 2021 | News

LISCure, the first Korean biotech company receiving equity investment from Mayo Clinic

LISCure Biosciences, Inc. ("LISCure") has entered into a know-how license and development collaboration agreement, and stock purchase agreement with Mayo C...

July 26, 2021 | News

Hyundai Mobis introduces the world first brainwaves based ADAS system, M.Brain.

- The new technology, 'M. Brain' identifies the driver's state through brainwaves and reduces accidents caused by drowsy driving or negligence. - Will tes...

July 22, 2021 | News

Samsung Biologics and Kineta Announce CDMO Agreement

Kineta to leverage Samsung Biologics' development and manufacturing expertise to advance KVA12.1 to IND Samsung Biologics San Francisco R&D cent...

July 21, 2021 | News

Digital New Deal Startups Gain Global Attention

Since 2020, the Ministry of Science and ICT has actively implemented the Korean Digital New Deal as a means of overcoming the economic hardships caused by ...

July 20, 2021 | News

Konyang University Hospital in South Korea relies on Molecular Health's MH Guide for personalized cancer medicine

It makes Konyang University Hospital the first facility in South Korea to use MH Guide. "Precision medicine in cancer care enables personalized treat...

July 16, 2021 | News

Y-Biologics & Pierre Fabre enter into an agreement in the field of immuno-oncology

These antibodies have been functionally validated by the Pierre Fabre R&D teams for their specific properties on a pivotal immuno-oncology target actin...

July 06, 2021 | News

Korea (KNIH) conducts field inspection of companies with mRNA technology

Korea National Institute of Health (KNIH), Korea's top research center in the field of hygiene and medicine (with Mr. Kwon Jun-Wook as President) conducted...

July 02, 2021 | News

VUNO Inks Deal with Samsung to Upgrade Premium Mobile X-ray System

South Korean artificial intelligence (AI) developer, VUNO Inc., announced today a partnership with Samsung Electronics Co., Ltd., global medical device com...

July 01, 2021 | News

People-Centric 'Korean Digital New Deal'

The Born2Global Centre, a part of the Korean Ministry of Science and ICT (MSIT), releases the following article that highlights the "My Data" ini...

June 25, 2021 | News

Stay Connected